Effect of TyG Index on Outcomes of Radical Prostatectomy

We investigate the association between Triglyserid-Glucose(TyG) index and prostate cancer in patients undergoing radical prostatectomy.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Metabolic Syndrome Genital Diseases Genital Diseases, Male Genital Neoplasms, Male Glucose Metabolism Disorders Hyperinsulinism Insulin Resistance Male Urogenital Diseases Metabolic Diseases Neoplasms Neoplasms by Site Nutritional and Metabolic Diseases Prostate Cancer Prostatic Diseases Prostatic Neoplasms Urogenital Diseases Urogenital Neoplasms

Sex eligibility

Male

Study type

Observational

About this study

TyG index is calculated with special formula. Patients undergoing radical prostatectomy are divided two groups according to the cut-off level of 8.55 for TyG index.Groups were compared statistically in terms of oncological outcomes and survival.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients undergoing radical prostatectomy for prostate cancer

Exclusion criteria

taking medicines for established diabetes and dyslipidaemia,
presence of endocrinological disease,
history of bariatric surgery,
missing data and patients with uncontrolled follow-up

Treatment and study plan

Primary outcomes

Oncological outcomes

Time frame: 5 years

Effect of TyG index on oncological outcomes of Prostate cancer

Secondary outcomes

Survival

Time frame: 5 years

Death date of patient after radical prostatectomy

Sponsors and collaborators

Lead sponsor

Recep Tayyip Erdogan University Training and Research Hospital

Other

Registry information

Official study title

A Novel Prognostic Risk Factor for Patients Undergoing Radical Prostatectomy: Triglyseride-Glucose (TyG) Index

Acronym: TyG-PCa

Important dates

Study start: 2007
Primary completion: 2012
Study completion: 2012
First posted: Feb 27, 2018
Registry last updated: Feb 27, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed